Rajiv I. Nijhawan, M.D. is double board-certified in both dermatology as well as micrographic dermatologic surgery. He is ACMS fellowship trained in Mohs Micrographic and Reconstructive Surgery. He specializes in the surgical management of skin cancers (such as basal cell carcinoma, squamous cell carcinoma, melanoma, and other rare skin cancers) as well as reconstructive surgery. He is an Associate Professor of Dermatology at UT Southwestern Medical Center and the Director of the Parkland Memorial Hospital Skin Tumor Clinic. In addition, he is the Director of the UTSW High Risk Skin Cancer Transplant Clinic and Assistant Fellowship Program Director of the UTSW Micrographic Surgery & Dermatologic Oncology Fellowship. 

Dr. Nijhawan completed a highly competitive six-year accelerated combined Bachelor’s and Medical Degree (BS/MD) program at the University of Miami School of Medicine. He graduated with research distinction and at the top of his class as a member of the Alpha Omega Alpha (AOA) Honor Medical Society. As a medical student, he was also inducted to the Iron Arrow Honor Society - considered the highest honor attained at the university. He subsequently completed dermatology residency training at St. Luke’s-Roosevelt Hospital in New York City where he served as chief resident. He then pursued advanced procedural dermatology training through a fellowship in Mohs Micrographic Surgery, reconstructive surgery, and cosmetic dermatology at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, also in New York City.

Dr. Nijhawan has conducted research on a wide range of dermatologic subspecialties. His work has been published widely in scientific journals, and he has presented at numerous national meetings. He is passionate about providing the highest quality of care for each and every patient he sees as well as advancing the field of dermatology. 



Medical School
University of Miami Miller School of Medicine (2009)
Columbia University/St. Luke's - Roosevelt Hospital Center (2010), Internal Medicine
St. Luke's - Roosevelt Hospital Center, Columbia University (2013), Dermatology
Memorial Sloan Kettering Cancer Center & Weill Cornell Medical College (2014), Procedural Dermatology/Mohs Micrographic Surgery

Research Interest

  • High Risk Skin Cancer
  • Melanoma
  • Mohs Surgery
  • Non-Melanoma Skin Cancer
  • Patient Safety
  • Patient Satisfaction
  • Reconstructive Surgery
  • Resident Education
  • Skin Cancer in Transplant Recipients


Featured Publications LegendFeatured Publications

Cells to Surgery Quiz: June 2021.
Nemeh MN, Nijhawan RI, J Invest Dermatol 2021 Jun 141 6 e71-e76
Oncologic outcomes in primary squamous cell carcinoma of the auricle: a retrospective cohort analysis.
Tanamal PJ, Geng CX, Nijhawan RI, Wynings E, Balachandra S, Myers LL, Tillman BN, Day AT, Eur Arch Otorhinolaryngol 2021 May
Preventing complications in dermatologic surgery: Presurgical concerns.
Strickler AG, Shah P, Bajaj S, Mizuguchi R, Nijhawan RI, Odueyungbo M, Rossi A, Ratner D, J Am Acad Dermatol 2021 Apr 84 4 883-892
Preventing and managing complications in dermatologic surgery: Procedural and postsurgical concerns.
Strickler AG, Shah P, Bajaj S, Mizuguchi R, Nijhawan RI, Odueyungbo M, Rossi A, Ratner D, J Am Acad Dermatol 2021 Apr 84 4 895-903
Using sterile adhesive bandages to maintain a sterile field during dermatologic surgery.
Curtiss P, Davis D, Srivastava D, Nijhawan RI, J Am Acad Dermatol 2021 Apr
Commentary on "Limitations in the literature regarding Mohs surgery and staged excision for melanoma: A critical review of quality and data reporting".
Miller CJ, Etzkorn JR, Leitenberger JJ, Bar A, Baum CL, Brewer JD, Srivastava D, Nijhawan RI, J Am Acad Dermatol 2021 Apr
The Nose Knows That Margins Matter.
Day AT, Salley JR, Nijhawan RI, Ann Surg Oncol 2021 Mar
Basal cell carcinoma histopathologic upgrading and Mohs micrographic surgery: a single institution, retrospective review.
Walocko F, Chelliah P, Kolitz E, Awerman J, Nijhawan RI, Srivastava D, Arch Dermatol Res 2021 Mar
Pharmacogenomics of Fluoropyrimidines-a Personalized Approach for Treating and Preventing Keratinocyte Carcinomas-Reply.
Schauder DM, Nijhawan RI, JAMA Dermatol 2021 Mar 157 3 358
Cells to Surgery Quiz: February 2021.
Greif CS, Nijhawan RI, J Invest Dermatol 2021 Feb 141 2 e21-e25


Featured Books Legend Featured Books

Professional Associations/Affiliations

  • Alpha Epsilon Lamba Graduate Honor Society (2006)
  • Alpha Omega Alpha Honor Medical Society (2008)
  • American Academy of Dermatology (2010)
  • American College of Mohs Surgery (2013)
  • American Society for Dermatologic Surgery (2010)